← Back to directory
Antoni Ribas
Researcher Next ID · RN-001258
Researcher · Medicine
Los Angeles, United States
Not currently recruitingFunding unknown
- Works count
- 1,732
- Citation count
- 166,961
- H-index
- 162
- i10-index
- 537
Research interests
Medicine
Biochemistry, Genetics and Molecular Biology
Immunology and Microbiology
Cancer Immunotherapy and Biomarkers
CAR-T cell therapy research
Melanoma and MAPK Pathways
Immunotherapy and Immune Responses
Cutaneous Melanoma Detection and Management
Publications
Cancer immunotherapy using checkpoint blockade
Science · 2018 · https://doi.org/10.1126/science.aar4060
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Cell · 2017 · https://doi.org/10.1016/j.cell.2017.01.017
Pembrolizumab versus Ipilimumab in Advanced Melanoma
New England Journal of Medicine · 2015 · https://doi.org/10.1056/nejmoa1503093
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Nature · 2014 · https://doi.org/10.1038/nature13954
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
New England Journal of Medicine · 2011 · https://doi.org/10.1056/nejmoa1103782
Current projects
No projects listed.